Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Arrowhead Pharma Q1 EPS $(1.24) Misses $(0.82) Estimate, Sales $3.55M Miss $29.51M Estimate

Author: Benzinga Newsdesk | February 06, 2024 05:07pm
Arrowhead Pharma (NASDAQ:ARWR) reported quarterly losses of $(1.24) per share which missed the analyst consensus estimate of $(0.82) by 51.22 percent. This is a 217.95 percent decrease over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $3.55 million which missed the analyst consensus estimate of $29.51 million by 87.97 percent. This is a 94.32 percent decrease over sales of $62.55 million the same period last year.

Posted In: ARWR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist